Zanzalintinib demonstrated antitumor activity in patients with heavily pretreated, advanced clear cell RCC in a phase 1 trial. Zanzalintinib demonstrated antitumor activity in patients with heavily pretreated, advanced clear cell RCC in a phase 1 trial.

Related Keywords

California , United States , America , Sumantak Pal , , City Of Hope Comprehensive Cancer Center , Hope Comprehensive Cancer Center ,